The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity.

The NAD(+)/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling. Cell (2013) 3.50

Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice. Science (2013) 2.49

NAD+ and sirtuins in aging and disease. Trends Cell Biol (2014) 2.07

Mechanism of inhibition of the human sirtuin enzyme SIRT3 by nicotinamide: computational and experimental studies. PLoS One (2014) 2.02

Metabolic control of autophagy. Cell (2014) 1.90

SIRT1 and other sirtuins in metabolism. Trends Endocrinol Metab (2013) 1.90

The nexus of chromatin regulation and intermediary metabolism. Nature (2013) 1.87

Pharmacological approaches to restore mitochondrial function. Nat Rev Drug Discov (2013) 1.66

Activation of SIRT3 by the NAD⁺ precursor nicotinamide riboside protects from noise-induced hearing loss. Cell Metab (2014) 1.66

Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice. Hepatology (2015) 1.56

The dynamic regulation of NAD metabolism in mitochondria. Trends Endocrinol Metab (2012) 1.55

Defective mitophagy in XPA via PARP-1 hyperactivation and NAD(+)/SIRT1 reduction. Cell (2014) 1.46

Interventions to Slow Aging in Humans: Are We Ready? Aging Cell (2015) 1.46

NAMPT-Mediated NAD(+) Biosynthesis Is Essential for Vision In Mice. Cell Rep (2016) 1.40

NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus. Cell Metab (2015) 1.38

Sirtuins: guardians of mammalian healthspan. Trends Genet (2014) 1.36

Dietary and metabolic control of stem cell function in physiology and cancer. Cell Stem Cell (2014) 1.29

Integration of clinical data with a genome-scale metabolic model of the human adipocyte. Mol Syst Biol (2013) 1.26

SIRT1 and energy metabolism. Acta Biochim Biophys Sin (Shanghai) (2013) 1.25

SIRT1 in neurodevelopment and brain senescence. Neuron (2014) 1.22

Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3. EMBO Mol Med (2014) 1.21

Metabolic inflexibility: when mitochondrial indecision leads to metabolic gridlock. Cell (2014) 1.20

Elevated microRNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT. Aging Cell (2013) 1.19

NAD(+)-dependent activation of Sirt1 corrects the phenotype in a mouse model of mitochondrial disease. Cell Metab (2014) 1.18

Mitochondrial protein acetylation as a cell-intrinsic, evolutionary driver of fat storage: chemical and metabolic logic of acetyl-lysine modifications. Crit Rev Biochem Mol Biol (2013) 1.17

PPARα and Sirt1 mediate erythropoietin action in increasing metabolic activity and browning of white adipocytes to protect against obesity and metabolic disorders. Diabetes (2013) 1.12

NAD⁺ metabolism: a therapeutic target for age-related metabolic disease. Crit Rev Biochem Mol Biol (2013) 1.11

Protective effects of sirtuins in cardiovascular diseases: from bench to bedside. Eur Heart J (2015) 1.11

The importance of NAMPT/NAD/SIRT1 in the systemic regulation of metabolism and ageing. Diabetes Obes Metab (2013) 1.10

Exploring the therapeutic space around NAD+. J Cell Biol (2012) 1.09

Loss of the RNA polymerase III repressor MAF1 confers obesity resistance. Genes Dev (2015) 1.08

Physiological and pathophysiological roles of NAMPT and NAD metabolism. Nat Rev Endocrinol (2015) 1.06

Targeted, LCMS-based Metabolomics for Quantitative Measurement of NAD(+) Metabolites. Comput Struct Biotechnol J (2013) 1.01

Mitonuclear communication in homeostasis and stress. Nat Rev Mol Cell Biol (2016) 1.01

Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun (2016) 1.00

Type 5 adenylyl cyclase increases oxidative stress by transcriptional regulation of manganese superoxide dismutase via the SIRT1/FoxO3a pathway. Circulation (2013) 0.99

Hepatic NAD(+) deficiency as a therapeutic target for non-alcoholic fatty liver disease in ageing. Br J Pharmacol (2016) 0.98

Resveratrol induces a mitochondrial complex I-dependent increase in NADH oxidation responsible for sirtuin activation in liver cells. J Biol Chem (2013) 0.98

Metabolic and neuropsychiatric effects of calorie restriction and sirtuins. Annu Rev Physiol (2012) 0.98

Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization. Nat Med (2015) 0.97

Protein acetylation in metabolism - metabolites and cofactors. Nat Rev Endocrinol (2015) 0.97

Aberrant protein acylation is a common observation in inborn errors of acyl-CoA metabolism. J Inherit Metab Dis (2014) 0.97

Erythropoietin, a novel versatile player regulating energy metabolism beyond the erythroid system. Int J Biol Sci (2014) 0.96

Intracellular redox state revealed by in vivo (31) P MRS measurement of NAD(+) and NADH contents in brains. Magn Reson Med (2013) 0.95

Mitochondrial response to nutrient availability and its role in metabolic disease. EMBO Mol Med (2014) 0.94

Mitochondrial biogenesis through activation of nuclear signaling proteins. Cold Spring Harb Perspect Biol (2013) 0.94

In vivo NAD assay reveals the intracellular NAD contents and redox state in healthy human brain and their age dependences. Proc Natl Acad Sci U S A (2015) 0.93

A method to identify and validate mitochondrial modulators using mammalian cells and the worm C. elegans. Sci Rep (2014) 0.93

Increasing NAD synthesis in muscle via nicotinamide phosphoribosyltransferase is not sufficient to promote oxidative metabolism. J Biol Chem (2014) 0.92

Sirtuins, metabolism, and DNA repair. Curr Opin Genet Dev (2014) 0.92

Geroncogenesis: metabolic changes during aging as a driver of tumorigenesis. Cancer Cell (2014) 0.92

Accurate measurement of nicotinamide adenine dinucleotide (NAD⁺) with high-performance liquid chromatography. Methods Mol Biol (2013) 0.91

High-fat diet-induced impairment of skeletal muscle insulin sensitivity is not prevented by SIRT1 overexpression. Am J Physiol Endocrinol Metab (2014) 0.90

Skeletal muscle mitochondria as a target to prevent or treat type 2 diabetes mellitus. Nat Rev Endocrinol (2016) 0.90

CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism. Cell Metab (2016) 0.89

Evidence for a direct effect of the NAD+ precursor acipimox on muscle mitochondrial function in humans. Diabetes (2014) 0.89

Metabolism leaves its mark on the powerhouse: recent progress in post-translational modifications of lysine in mitochondria. Front Physiol (2014) 0.89

Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: evidence for improved neuronal bioenergetics and autophagy procession. Neurobiol Aging (2012) 0.89

Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes. Mol Aspects Med (2013) 0.89

Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice. Sci Rep (2016) 0.89

Lethal Cardiomyopathy in Mice Lacking Transferrin Receptor in the Heart. Cell Rep (2015) 0.88

Primary respiratory chain disease causes tissue-specific dysregulation of the global transcriptome and nutrient-sensing signaling network. PLoS One (2013) 0.88

WISP1: Clinical insights for a proliferative and restorative member of the CCN family. Curr Neurovasc Res (2014) 0.88

New facets in the regulation of gene expression by ADP-ribosylation and poly(ADP-ribose) polymerases. Chem Rev (2015) 0.88

Systemic regulation of mammalian ageing and longevity by brain sirtuins. Nat Commun (2014) 0.87

Hypothalamic SIRT1 prevents age-associated weight gain by improving leptin sensitivity in mice. Diabetologia (2013) 0.87

SIRT3: A Central Regulator of Mitochondrial Adaptation in Health and Disease. Genes Cancer (2013) 0.86

Metabolic control of methylation and acetylation. Curr Opin Chem Biol (2015) 0.86

Novel directions for diabetes mellitus drug discovery. Expert Opin Drug Discov (2012) 0.86

Resveratrol improves the mitochondrial function and fertilization outcome of bovine oocytes. J Reprod Dev (2013) 0.86

Regulation of SIRT1 by microRNAs. Mol Cells (2013) 0.86

The human NAD metabolome: Functions, metabolism and compartmentalization. Crit Rev Biochem Mol Biol (2015) 0.86

Slowing ageing by design: the rise of NAD(+) and sirtuin-activating compounds. Nat Rev Mol Cell Biol (2016) 0.86

Habitual exercise plus dietary supplementation with milk fat globule membrane improves muscle function deficits via neuromuscular development in senescence-accelerated mice. Springerplus (2014) 0.85

Metabolic profiling of alternative NAD biosynthetic routes in mouse tissues. PLoS One (2014) 0.85

NAD and the aging process: Role in life, death and everything in between. Mol Cell Endocrinol (2016) 0.85

Macrophage migration inhibitory factor (MIF) knockout preserves cardiac homeostasis through alleviating Akt-mediated myocardial autophagy suppression in high-fat diet-induced obesity. Int J Obes (Lond) (2014) 0.84

The Molecular Circadian Clock and Alcohol-Induced Liver Injury. Biomolecules (2015) 0.84

Nicotinamide mononucleotide supplementation reverses vascular dysfunction and oxidative stress with aging in mice. Aging Cell (2016) 0.84

Disruption of uridine homeostasis links liver pyrimidine metabolism to lipid accumulation. J Lipid Res (2013) 0.83

Nicotinamide pre-treatment ameliorates NAD(H) hyperoxidation and improves neuronal function after severe hypoxia. Neurobiol Dis (2013) 0.83

SIRT1 enhances glucose tolerance by potentiating brown adipose tissue function. Mol Metab (2014) 0.83

The beneficial role of vitamin D in obesity: possible genetic and cell signaling mechanisms. Nutr J (2013) 0.83

Environment Dictates Dependence on Mitochondrial Complex I for NAD+ and Aspartate Production and Determines Cancer Cell Sensitivity to Metformin. Cell Metab (2016) 0.83

Overexpression of SIRT1 in rat skeletal muscle does not alter glucose induced insulin resistance. PLoS One (2015) 0.83

Mangiferin stimulates carbohydrate oxidation and protects against metabolic disorders induced by high-fat diets. Diabetes (2014) 0.82

Novel targets for mitochondrial medicine. Sci Transl Med (2016) 0.82

Loss of NAD Homeostasis Leads to Progressive and Reversible Degeneration of Skeletal Muscle. Cell Metab (2016) 0.82

NAD+ and SIRT3 control microtubule dynamics and reduce susceptibility to antimicrotubule agents. Proc Natl Acad Sci U S A (2014) 0.81

OXPHOS-Mediated Induction of NAD+ Promotes Complete Oxidation of Fatty Acids and Interdicts Non-Alcoholic Fatty Liver Disease. PLoS One (2015) 0.81

The transcriptional regulator of the chaperone response HSF1 controls hepatic bioenergetics and protein homeostasis. J Cell Biol (2017) 0.81

Potential Modulation of Sirtuins by Oxidative Stress. Oxid Med Cell Longev (2015) 0.81

Age-Associated Weight Gain, Leptin, and SIRT1: A Possible Role for Hypothalamic SIRT1 in the Prevention of Weight Gain and Aging through Modulation of Leptin Sensitivity. Front Endocrinol (Lausanne) (2015) 0.81

Generation, Release, and Uptake of the NAD Precursor Nicotinic Acid Riboside by Human Cells. J Biol Chem (2015) 0.80

Normalization of NAD+ Redox Balance as a Therapy for Heart Failure. Circulation (2016) 0.80

When stem cells grow old: phenotypes and mechanisms of stem cell aging. Development (2016) 0.80

NAD(+) Metabolism in Age-Related Hearing Loss. Aging Dis (2014) 0.79

Sirtuin deacetylases as therapeutic targets in the nervous system. Neurotherapeutics (2013) 0.79

Relationship between mitochondrial DNA copy number and SIRT1 expression in porcine oocytes. PLoS One (2014) 0.79

The endothelium abridges insulin resistance to premature aging. J Am Heart Assoc (2013) 0.79

Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature (2000) 20.54

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell (2006) 19.16

Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature (2005) 18.41

Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science (2004) 17.38

AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature (2009) 10.59

The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell (2003) 8.34

A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc Natl Acad Sci U S A (2008) 6.53

Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell (2007) 6.47

The FoxO code. Oncogene (2008) 6.22

Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol (2005) 5.54

Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science (2009) 5.30

Sirt1 protects against high-fat diet-induced metabolic damage. Proc Natl Acad Sci U S A (2008) 5.21

SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol Cell (2007) 5.01

Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab (2010) 4.97

SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell (2002) 4.31

Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab (2007) 4.16

Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. J Biol Chem (2003) 4.12

Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab (2011) 3.38

SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol Cell (2011) 3.33

The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr Rev (2009) 3.23

PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat Med (2003) 2.97

PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab (2011) 2.94

Nicotinamide riboside promotes Sir2 silencing and extends lifespan via Nrk and Urh1/Pnp1/Meu1 pathways to NAD+. Cell (2007) 2.83

Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. Cell (2004) 2.71

Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. Genes Dev (2010) 2.55

Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annu Rev Nutr (2008) 2.48

FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. Cell Metab (2009) 2.27

Structure and dynamics of the mitochondrial inner membrane cristae. Biochim Biophys Acta (2006) 1.98

GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. J Clin Invest (2005) 1.88

Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)? Pharmacol Rev (2011) 1.85

Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation. J Biol Chem (2011) 1.76

The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of diet-induced obesity. FASEB J (2007) 1.57

NAD metabolism and sirtuins: metabolic regulation of protein deacetylation in stress and toxicity. AAPS J (2006) 1.57

PARP-2 regulates SIRT1 expression and whole-body energy expenditure. Cell Metab (2011) 1.55

Genetic background determines metabolic phenotypes in the mouse. Mamm Genome (2008) 1.51

PGC-1alpha activates CYP7A1 and bile acid biosynthesis. J Biol Chem (2003) 1.49

Sir2: an NAD-dependent histone deacetylase that connects chromatin silencing, metabolism, and aging. Cold Spring Harb Symp Quant Biol (2000) 1.41

The nicotinic acid receptor--a new mechanism for an old drug. Lancet (2004) 1.19

Syntheses of nicotinamide riboside and derivatives: effective agents for increasing nicotinamide adenine dinucleotide concentrations in mammalian cells. J Med Chem (2007) 1.11

A novel muscle-specific beta 1 integrin binding protein (MIBP) that modulates myogenic differentiation. J Cell Biol (1999) 0.99

Nicotinamide phosphoribosyltransferase/visfatin does not catalyze nicotinamide mononucleotide formation in blood plasma. PLoS One (2011) 0.97

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell (2006) 19.16

Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature (2004) 12.36

AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature (2009) 10.59

Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature (2006) 9.36

TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab (2009) 6.91

Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell (2007) 6.47

Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell (2008) 5.51

Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab (2008) 5.44

Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest (2004) 4.65

Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov (2008) 4.43

Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab (2008) 4.36

SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell (2002) 4.31

Mitonuclear protein imbalance as a conserved longevity mechanism. Nature (2013) 4.18

Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science (2011) 4.16

Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β. Nature (2012) 4.15

PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol (2009) 4.09

Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci U S A (2003) 4.03

A guide to analysis of mouse energy metabolism. Nat Methods (2011) 3.82

The NAD(+)/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling. Cell (2013) 3.50

International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev (2006) 3.48

Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab (2010) 3.46

Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members. J Biol Chem (2003) 3.41

Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem (2006) 3.40

The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr Rev (2009) 3.23

Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62. Cell Metab (2006) 3.22

Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring) (2009) 3.15

Endocrine functions of bile acids. EMBO J (2006) 3.03

Nuclear receptors and the control of metabolism. Annu Rev Physiol (2002) 3.00

Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis. Am J Clin Nutr (2011) 2.98

NCoR1 is a conserved physiological modulator of muscle mass and oxidative function. Cell (2011) 2.75

E2Fs regulate adipocyte differentiation. Dev Cell (2002) 2.71

Sirtuins: the 'magnificent seven', function, metabolism and longevity. Ann Med (2007) 2.64

The retinoblastoma-histone deacetylase 3 complex inhibits PPARgamma and adipocyte differentiation. Dev Cell (2002) 2.61

SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1. J Biol Chem (2005) 2.59

Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology (2003) 2.59

Transcriptional coregulators in the control of energy homeostasis. Trends Cell Biol (2007) 2.40

Sirtuin functions in health and disease. Mol Endocrinol (2007) 2.38

Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation. Mol Cell (2004) 2.31

Adipocyte NCoR knockout decreases PPARγ phosphorylation and enhances PPARγ activity and insulin sensitivity. Cell (2011) 2.26

LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis. Trends Cell Biol (2004) 2.24

SIRT1 and endocrine signaling. Trends Endocrinol Metab (2006) 2.17

TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metab (2011) 2.17

Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma. J Exp Med (2005) 2.06

Cardiolipin provides an essential activating platform for caspase-8 on mitochondria. J Cell Biol (2008) 2.06

mTOR complex 2 in adipose tissue negatively controls whole-body growth. Proc Natl Acad Sci U S A (2009) 2.05

Histone methyl transferases and demethylases; can they link metabolism and transcription? Cell Metab (2010) 2.04

Peroxisome proliferator-activated receptor-gamma calls for activation in moderation: lessons from genetics and pharmacology. Endocr Rev (2004) 2.04

Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest (2006) 2.03

The pollutant diethylhexyl phthalate regulates hepatic energy metabolism via species-specific PPARalpha-dependent mechanisms. Environ Health Perspect (2010) 1.98

AMP-activated protein kinase and its downstream transcriptional pathways. Cell Mol Life Sci (2010) 1.95

The metabolic footprint of aging in mice. Sci Rep (2011) 1.93

Hormonal control of androgen receptor function through SIRT1. Mol Cell Biol (2006) 1.91

Caloric restriction, SIRT1 and longevity. Trends Endocrinol Metab (2009) 1.89

Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR gamma hypomorphic mice. Proc Natl Acad Sci U S A (2003) 1.89

Compromised intestinal lipid absorption in mice with a liver-specific deficiency of liver receptor homolog 1. Mol Cell Biol (2007) 1.89

PPAR(gamma) and glucose homeostasis. Annu Rev Nutr (2002) 1.86

Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies. J Med Chem (2008) 1.85

Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)? Pharmacol Rev (2011) 1.85

Peroxisome proliferator-activated receptor alpha agonists increase nitric oxide synthase expression in vascular endothelial cells. Arterioscler Thromb Vasc Biol (2004) 1.83

SRT1720 improves survival and healthspan of obese mice. Sci Rep (2011) 1.81

The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1{alpha}. Proc Natl Acad Sci U S A (2008) 1.80

Metabolic networks of longevity. Cell (2010) 1.79

Reliability, robustness, and reproducibility in mouse behavioral phenotyping: a cross-laboratory study. Physiol Genomics (2008) 1.76

2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease. Ther Apher Dial (2010) 1.71

Enzymes in the NAD+ salvage pathway regulate SIRT1 activity at target gene promoters. J Biol Chem (2009) 1.70

The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation. J Hepatol (2010) 1.69

Peroxisome proliferator-activated receptor (PPAR)-beta/delta stimulates differentiation and lipid accumulation in keratinocytes. J Invest Dermatol (2004) 1.69

CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance. Cell Metab (2009) 1.68

Pharmacological approaches to restore mitochondrial function. Nat Rev Drug Discov (2013) 1.66

Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells. Genes Dev (2012) 1.64

Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure. J Biol Chem (2011) 1.62

The role of sirtuins in the control of metabolic homeostasis. Ann N Y Acad Sci (2009) 1.62

Adipose-specific expression, phosphorylation of Ser794 in insulin receptor substrate-1, and activation in diabetic animals of salt-inducible kinase-2. J Biol Chem (2003) 1.62

4-Hydroxy-2-pyridone alkaloids: structures and synthetic approaches. Nat Prod Rep (2010) 1.62